MedPath

Lysine-specific Demethylase 1 and Salt-sensitivity in Humans

Not Applicable
Active, not recruiting
Conditions
Healthy Subjects
Interventions
Other: Aldosterone response to AngII LS
Other: Renal blood flow response to salt
Other: Vascular Stiffness
Registration Number
NCT03029806
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.

Detailed Description

The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure in African American and Caucasians, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1. This might help us understand why some people develop high blood pressure.

Healthy volunteers will be screened for eligibility and invited to participate in a 2 weeks study. Week 1 will be consumption of a low salt diet. Week 2 will be a high salt diet.

At the end of each week, participants will be admitted to a Clinical Research Center overnight and for one day.

On the CRC, participants will remain fasting and supine overnight and then next morning undergo hormonal and vascular testing. This will consist of blood drawing, echocardiogram, vascular tonometry, and assessment of renal blood flow before and after a low-dose Angiotensin II infusion.

The study outcome will compare how variants in the LSD1 gene affect hormonal and vascular responses according to race. This information will help us determine why some races and genetic profiles are more susceptible to detrimental effects of salt in the diet while others are protected against these effects.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Age 25-45 years
  • Caucasian or African American
  • No gender preference (anticipate 50% female)
  • Normotensive (screening blood pressure <140/90 mmHg)
  • No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months
  • Normal screening laboratory values (CMP, TSH, A1c)
  • Normal ECG
  • BMI <25 kg/m2
Exclusion Criteria
  • Pregnancy
  • Breast feeding
  • Any medication or herbal preparation
  • >6oz alcohol/week
  • Tobacco use
  • Illicit drug use
  • Chronic NSAID use
  • Recent steroid use (injected, inhaled, oral)
  • Decongestant use in the past 2 weeks
  • Known sensitivity to infused Angiotensin II or para-amino hippurate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Afr-Amer risk alleleRenal blood flow response to saltAfrican Americans carrying the LSD1 affected allele
Afr-Amer risk alleleVascular StiffnessAfrican Americans carrying the LSD1 affected allele
Afr-Amer risk alleleAldosterone response to AngII LSAfrican Americans carrying the LSD1 affected allele
Afr-Amer non-risk alleleAldosterone response to AngII LSAfrican Americans carrying the LSD1 non-risk allele
Cauc risk alleleRenal blood flow response to saltCaucasians carrying the LSD1 affected allele
Cauc risk alleleVascular StiffnessCaucasians carrying the LSD1 affected allele
Cauc non-risk alleleRenal blood flow response to saltCaucasians carrying the LSD1 non-risk allele
Cauc risk alleleAldosterone response to AngII LSCaucasians carrying the LSD1 affected allele
Afr-Amer non-risk alleleRenal blood flow response to saltAfrican Americans carrying the LSD1 non-risk allele
Afr-Amer non-risk alleleVascular StiffnessAfrican Americans carrying the LSD1 non-risk allele
Cauc non-risk alleleAldosterone response to AngII LSCaucasians carrying the LSD1 non-risk allele
Cauc non-risk alleleVascular StiffnessCaucasians carrying the LSD1 non-risk allele
Primary Outcome Measures
NameTimeMethod
Aldosterone response to angiotensin IIAfter 1 week dietary salt manipulation

Change in aldosterone, baseline to after angiotensin II by genotype/race

Secondary Outcome Measures
NameTimeMethod
Vascular stiffness response to angiotensin IIAfter 1 week dietary salt manipulation

Change in vascular stiffness, baseline to after angiotensin II by genotype/race

Renal blood flow response to dietary saltAfter 1 week dietary salt manipulation on both diets

Change in renal blood flow, high salt diet to low salt diet by genotype/race

Trial Locations

Locations (1)

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath